A ground-breaking prostate cancer treatment that aims to target tumours without as many side effects has showed promising ...

Thousands of people living with advanced prostate cancer will have access to a life-extending new treatment that can be taken at home from today (Friday, 23 January). NICE has recommended talazoparib ...

Florida Cancer Specialists & Research Institute, LLC (FCS) is among the first oncology providers in Florida selected to ...

Investigators tested a new neoadjuvant immunotherapy to fight prostate cancer using a virus-mimicking drug to activate the immune system.

City of Hope ® , one of the largest and most advanced cancer research and treatment organizations in the United States with ...

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in clinical trials to cut the risk of death by more than 40%. Subscribe to our ...

A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, lowering the risk of death after eight years by 40.3%. What's more, the drug ...

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...

NHS England has announced that men whose high-risk prostate cancer has not yet spread will be able to receive the drug, abiraterone.

ETHealthworld.com brings latest prostate cancer news, views and updates from all top sources for the Indian Health industry.

Long-term exposure to vehicle pollution and nitrate emissions highlights the growing role of environmental factors in men’s cancer prevention ...